• acute
  • 6,7 The purpose of this review is to discuss the rationale and evidence for an endovascular treatment approach for high-risk acute DVT and PE patients. (acc.org)
  • it is estimated that over 100,000 deaths in hospitalized patients in the United States are attributable to acute PE each year. (acc.org)
  • 32,33 In contemporary practice, catheter-based endovascular therapy for acute PE can be considered in patients where there is a clear contraindication to full dose thrombolytic therapy or when risk stratification in a patient with stable hemodynamics indicates an increased likelihood of morbidity and mortality. (acc.org)
  • In a randomized, open-label, blinded, endpoints adjudication trial (PREPIC2) at 17 centers with 6 months of follow-up between 2006 and 2013, 399 hospitalized patients with an acute symptomatic PE and associated lower extremity venous thrombus were randomized to receive either an IVC filter plus anticoagulation or anticoagulation alone (primarily with a vitamin K antagonist). (acc.org)
  • The authors concluded that this study's results do not support the use of IVC filters in patients who can receive anticoagulation following an acute PE. (acc.org)
  • submassive
  • Whereas massive PE is defined by the presence of persistent hypotension, submassive PE is defined as occurring in normotensive patients with evidence of right ventricular (RV) strain by echocardiogram, computed tomography (CT) scan, or cardiac biomarkers. (onlinejacc.org)
  • stent
  • The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms. (stanford.edu)
  • major
  • The secondary objectives were to estimate the six-month major device-related adverse event rate in patients with a converted filter and to determine the device deployment success rate. (interventionalnews.com)
  • therapy
  • Long-term risk factors must be considered as well, to include life expectancy of more than six months following insertion, and the ability of the patient to comply with anticoagulation therapy. (wikipedia.org)
  • Proven VTE: High risk of contraindication or complication to arise during anticoagulation therapy Large, free-floating proximal DVT's Poor Compliance: INR levels are not stable, not taking medicine as directed Thrombolysis: Iliocaval DVT's, which are emboli in the Illiac region These are usually very controversial reasons to do an IVC filter, and most radiologists and doctors generally will not recommend an IVC filter if other options are available instead. (wikipedia.org)
  • No VTE: Anticoagulation therapy is not possible (high risk of bleeding) Transient risk of VTE: Trauma, surgical procedures or medical conditions Bariatric patients: Undergoing surgery for weight control, only if BMI greater than 55, previous history of DVT/PE, hypercoagulable state, chronic venous insufficiency, truncal obesity or contraindication to anticoagulation therapy. (wikipedia.org)
  • risk
  • The trial also demonstrated the success of modern anticoagulation strategies to reduce the risk of PE recurrence, as low as 1.5% at 3 months of follow-up. (acc.org)
  • However, at least in the U.S., there is a huge percentage of patients (66% in 2014) who still have their IVC filters long after the risk of PE has passed. (dangerousdrugs.us)
  • The FDA has issued two safety alerts recommending that IVC filters be removed once the risk of PE has passed. (dangerousdrugs.us)
  • lower
  • Although anticoagulation is effective in preventing PE, many patients go on to experience post-thrombotic syndrome, which is a chronic sequelae of DVT, with resultant valvular insufficiency of the lower extremity. (evtoday.com)
  • severe
  • Dr. Arko's facility doesn't use IVC filters in trauma patients, however he knows of prophylactic use in severe trauma cases, such as closed head injuries, spinal cord injuries and long bone or pelvic fractures. (dangerousdrugs.us)
  • adverse
  • The IVC Filter lawsuits claim that the manufacturers of these cage-like, spider- shaped wire devices failed to warn physicians and patients of the dangers of multiple serious adverse events (SAEs). (quellerfisher.com)
  • guidelines
  • The interviewees were questioned as to what guidelines they and their respective facilities followed re: implanting IVC filters. (dangerousdrugs.us)
  • Their answers point to a problem in the field: namely, that there isn't one uniform set of guidelines for IVC filter use and that they differ across the board. (dangerousdrugs.us)
  • possible
  • A consultation with us regarding your possible IVC filter case is a completely free consult. (quellerfisher.com)
  • 2) Provide an ongoing post-market surveillance mechanism for documentation of clinical outcomes and for possible extension of the Centers for Medicare and Medicaid Services (CMS) coverage to a broader group of patients. (stanford.edu)
  • removal
  • If the IVC filter is still necessary following that appointment, the clinic closely monitors patients and brings them in for removal once the conditions are met. (dangerousdrugs.us)
  • Likewise, Dr. Goh's facility uses an in-house registry, recording all IVC filter implants and projected dates for removal. (dangerousdrugs.us)
  • A removal appointment is typically set for six weeks post-implant and most of their patients undergo removal surgery at that appointment or a later rescheduled time. (dangerousdrugs.us)